Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A cohort of men and women aged from 2070 years who had been diagnosed with depression and had been admitted for treatment to two institutions in New York City were recruited for the study
the development, implementation and commercialization of its contemplated U.S.-focused peptide platform
Hybridization chain reaction-based DNA nanoframeworks for biosensing and therapeutic applications
The rats were administered IPA, GHRP-6, growth hormone (GH), or a vehicle for 12 weeks
US$ 21.52
US$ 28.63
US$ 20.18
US$ 25.65
